Quantcast

Latest Plateletpheresis Stories

2009-12-15 08:00:00

LAKE ZURICH, Ill., Dec. 15 /PRNewswire/ -- Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal approval to market InterSol® platelet additive solution. Fenwal® InterSol® solution is a specialized product used in combination with human plasma to store donated platelets, a vital blood...

2009-12-07 16:36:00

NEW ORLEANS, Dec. 7 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced results from its first Phase 1/2 study evaluating the safety and efficacy of Nplate® (romiplostim) in children with chronic immune thrombocytopenic purpura (ITP). Chronic ITP is a serious autoimmune disorder characterized by low platelet counts in the blood (thrombocytopenia), which can lead to serious bleeding events. The data were presented as an oral presentation at the 2009...

2009-12-06 12:21:00

NEW ORLEANS, Dec. 6 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS). MDS is a pre-leukemic condition in which early blood forming cells in the bone marrow are unable to mature normally, thereby limiting their ability to produce normal mature blood elements, which can lead to low platelet counts. The results of the...

2009-11-17 09:00:00

LAKE ZURICH, Ill., Nov. 17 /PRNewswire/ -- Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has cleared the Verax Platelet PGD® test as a quality control test to detect bacterial contamination in whole blood-derived, pooled platelets prior to transfusion. Fenwal is the exclusive global distributor of the test, which was developed by...

2009-10-30 16:00:00

NEW YORK, Oct. 30 /PRNewswire-USNewswire/ -- November is both Pancreatic Cancer Awareness Month and Lung Cancer Awareness Month, and New York Blood Center (NYBC) and its divisions in Manhattan, Long Island, Hudson Valley, Brooklyn/Staten Island, and New Jersey call upon the community to join the fight against cancer by donating blood today. Every two seconds, someone needs blood, and cancer patients may require frequent blood transfusions because aggressive treatment often destroys...

2009-08-25 00:06:08

Officials of the New York Blood Center are urging Americans to save a life and plan to donate blood before the Labor Day weekend. Summer is trauma season for most U.S. hospital emergency rooms because August has the highest number of vehicle collisions, the Insurance Institute for Highway Safety says. Collision and trauma victims may need as many as 50 or more red cell transfusions. Throughout the year, every two seconds, someone needs blood, officials of the New York Blood Center say....

2009-08-06 00:43:36

Blood transfusions for hospitalized cardiac patients should be a last resort because they double the risk of infection, U.S. researchers found. The study, published in BMC Medicine, found the risk of death following cardiac blood transfusions increased four-fold. The analysis of 30-day outcomes for nearly 25,000 Medicare coronary artery bypass graft surgery patients from 2003-2006 in 40 Michigan hospitals found transfusion practices vary substantially among hospitals. Study co-author Dr. Neil...

2009-06-07 02:43:00

BERLIN, June 7 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today released the results of a new study comparing Nplate(R) (romiplostim) to the medical standard of care (SOC) in non-splenectomised adult patients with chronic immune thrombocytopenic purpura (ITP). Chronic ITP is a serious autoimmune disorder characterised by low platelet counts in the blood (thrombocytopenia), which can lead to serious bleeding events. The study results show Nplate significantly reduced the incidences...

2009-02-06 16:45:00

First and Only Approved Platelet Producer in Europe Represents New Treatment Approach for Serious Chronic Autoimmune Disorder ZUG, Switzerland, Feb. 6 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced that the European Commission (EC) has granted marketing authorisation for Nplate(R) (romiplostim) for the treatment of splenectomised adult chronic immune (idiopathic) thrombocytopenic purpura (ITP) patients who are refractory to other treatments (e.g. corticosteroids,...

2009-01-13 09:42:00

Recession, Winter Weather Compound January's Blood Drain NEW YORK, Jan. 13 /PRNewswire-USNewswire/ -- New York Blood Center (NYBC) and its regional operations (serving New York City, Long Island, Hudson Valley and New Jersey) have issued an emergency appeal for blood donations. Hospital demand for blood (needed for emergency care and surgery) has increased beyond seasonal expectations while levels of blood donation have been below forecast. Blood supplies have dropped below the five-day...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.